US Patent Issued to GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS Co. LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY on May 13 for "Pyrazolopyridine compound as RET inhibitor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,197, issued on May 13, was assigned to GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS Co. LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY (Guangdong, China).

"Pyrazolopyridine compound as RET inhibitor and application thereof" was invented by Jiansong Wang (Guangdong, China), Zhengxia Chen (Shanghai), Zhibo Luo (Guangdong, China), Meibi Dai (Shanghai), Yang Zhang (Shanghai), Shuhui Chen (Shanghai), Yingxia Bao (Guangdong, China), Wei Wang (Guangdong, China) and Zhoufan Xie (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a series of pyrazolopyridine compounds, and application thereof in the preparation of RET kinase inhibit...